Find clinical trials for Prostate Cancer in Hanyang, Seoul
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Prostate Cancer trials near Hanyang, Seoul, KOR:
Purpose of the study was to assess the effect of enzalutamide on time to Prostate Specific Antigen (PSA) progression as compared to placebo ...
Phase 3
Seoul, Korea, Republic of and 46 other locations
8 weeks (±2 weeks) to patients with metastatic castration resistant prostate cancer (mCRPC) in order to assess the safety and effic...
Phase 2
Seoul, Korea, Republic of
and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...
Phase 3
Seoul, Korea, Republic of and 131 other locations
Evaluate the safety and tolerability of AMG 509 in adult participants and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2...
Phase 1
Seoul, Korea, Republic of and 44 other locations
plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednison...
Phase 2, Phase 3
Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of and 105 other locations
The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutam...
Phase 2
Seoul, Korea, Republic of and 220 other locations
examination to determine the presence of recurrent or metastatic prostate cancer in patients whose recurrent or metastatic lesions ...
Phase 3
Seoul, Korea, Republic of and 5 other locations
plus docetaxel in participants with metastatic castration resistant prostate cancer (mCRPC), all participants will receive the doce...
Phase 3
Seoul, Korea, Republic of and 249 other locations
The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...
Phase 3
Seoul, Korea, Republic of and 388 other locations
to radiographic progression-free survival (rPFS) per 1) Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 for soft tissue and/or Prostate...
Phase 3
Seoul, Korea, Republic of and 322 other locations
Clinical trials
Research sites
Resources
Legal